All News
Have you seen the MTX data regarding PsO? Dr. Gordon reviews the METOP data. My take homes: MTX has moderate efficacy and takes a long time! #RNL2022 @RheumNow https://t.co/B28onPUKn8
Dr. Rachel Tate uptoTate ( View Tweet)
Excellent charts presented by Dr. Kenneth Gordon on the PASI response and QoL response amongst different PsO therapies
@RheumNow #RNL2022 https://t.co/e3gqcPzk79
Robert B Chao, MD doctorRBC ( View Tweet)
How to treat #psoriasis #PsO Indivualize for pt. OK to try more than one drug within a class if initial fails or isn’t tolerated. Common I think to have 2ndary loss of response even with dose escalation. Skin is sneaky immunologically! #RNL2022 @RheumNow https://t.co/pFPNCVLSvk
Janet Pope Janetbirdope ( View Tweet)
#ClinicalPearl Fun fact According to Dr Strober IL17i have BEST effects on nail involvement in #psoriasis. I didn’t know. often need ⬆️dose over time #RNL2022 @RheumNow https://t.co/Y9U9c4M03j
Janet Pope Janetbirdope ( View Tweet)
Current treatment paradigm for PsO
@RheumNow #RNL2022 https://t.co/yDc3Pk0RjI
Robert B Chao, MD doctorRBC ( View Tweet)
#RNL2022 Psoriatic Disease for Rheumatologists with Drs. Gordon and Merida. https://t.co/PEj0dI7ucH
Dr. John Cush RheumNow ( View Tweet)
Learning so much this weekend at @rheumnow. Great talks this am on psoriatic disease for rheumatologists and on hot topics in rheumatology featuring adults with JIA, pain, and central sensitization in rheumatic disease. #RNL2022 https://t.co/UBbchcJu4B
Aradhna-Agarwal AradhnaAgarwal ( View Tweet)
"Asking a dermatologist to discuss the whole psoriatic disease patient is a little like asking a dog to do a haiku." Dr. Merola discusses combined derm-rheum clinics and collaborative care models for best care of patients. #RNL2022 @RheumNow https://t.co/u5mhpZunnt
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. J Merola recc patients download the Psorcast app; this tool helps patients with #psoriasis and #PsoriaticArthritis track their disease and support research (on App store, launched 1/2022) https://t.co/KLKv5nz4Bb #RNL2022 @rheumnow @CreakyJoints https://t.co/OMnAFJr4xY
TheDaoIndex KDAO2011 ( View Tweet)
Wow.. #JIA patients evolve into different categories over time. Dr Jon Hausmanns talk at #RNL2022 @hausmannMD https://t.co/fefXB2fFmJ
Dr. John Cush RheumNow ( View Tweet)
Role of combined clinic (derm rheum) in managing PsA.
Best way to help patient in my opinion!!
Joseph Merola @RheumNow #RNL2022 https://t.co/98i3qQ6rxp
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
#ClinicalPearl Patients with #psoriatic arthritis do better if #rheumatologists and #dermatologists work together. Many different models. More apt to get holistic Rx. Rheumatic are u less familiar with topicals for #psoriasis @RheumNow #RNL2022 Dr Joe Merida https://t.co/nVZe7ZwBqI
Janet Pope Janetbirdope ( View Tweet)
Derm please help, Joint improved but skin didn't!!
What to do?
Joseph Merola @RheumNow #rnl2022 https://t.co/DrmtEJZnBx
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Can we prevent PsA?!
That would be great!, studies are ongoing.
Joseph Merola @RheumNow #rnl2022 https://t.co/3c0duNQWGu
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
"Quality of life of the patient is maximized when we treat both skin and joints." Dr. Merola quoting Dr. Kavanaugh at #RNL2022 I would add treatment for any active domains improves QoL for our Psoriatic disease patients. @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Dr Joseph Merola presenting on collaborative Rheum-derm clinics for the care of psoriatic disease. https://t.co/K37HZazbtr has resources to facilitate. #RNL2022 https://t.co/9l3n5xzyjF
Links:
Dr. John Cush RheumNow ( View Tweet)
What's unique about the new Tyk2 inhibitor, deucravacitinib, under study in #PSO and #PsA. #RNL2022 https://t.co/J04uJxeX2v
Dr. John Cush RheumNow ( View Tweet)
Dr Bruce Strober reviews new classification scheme for psoriasis patients who are candidates for typical or systemic therapy. #RNL2022 https://t.co/bWVoIs3Vgn
Dr. John Cush RheumNow ( View Tweet)
Axial PsA Prevalence, Varies with disease duration!!
5 years duration 28%.
25 years duration 70%
Philip Mease @rheumnow #Rnl2022 https://t.co/w5aGiYJ6I0
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
#PsA axSpA Juvenile SpA great session @RheumNow #RNL2022. Lectures from gut microbiome to diff between #ankylosing #spondylitis vs axSpA to kid onset SpA. Lots of drugs coming to help out pts. https://t.co/IE8AlHS6hu
Janet Pope Janetbirdope ( View Tweet)
